The mutation in Philadelphia chromosome is a translocation, identified as, t(9;22)(q34;q11). This abnormal chromosome has a fusion gene, consisting of the ABL gene and the BCR gene, producing the BCR-ABL oncogene. This oncogene produces an enzyme that has a constitutive, abnormal tyrosine kinase activity. The existence of this fusion gene is necessary and sufficient for the generation of leukemia.